Connect Biopharma Ownership 2024 | Who Owns Connect Biopharma Now?
Institutional Ownership
7.17%
Insider Ownership
41.27%
Retail Ownership
51.56%
Institutional Holders
11.00
Connect Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 3.74% | 2.37% | 2,061,338 | -100 | -0.00% | 3,586,728 | Mar 31, 2024 |
| BLACKROCK INC. | 1.89% | - | 1,040,067 | - | - | 1,809,717 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.93% | 0.06% | 510,701 | -50,490 | -9.00% | 888,620 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 0.00% | 239,900 | -58,100 | -19.50% | 417,000 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 27,961 | - | - | 48,652 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 35,000 | Mar 31, 2024 |
| KEUDELL/MORRISON WEALTH MANAGEMENT | 0.04% | 0.01% | 19,700 | 8,500 | 75.89% | 34,278 | Mar 31, 2024 |
| RHUMBLINE ADVISERS | 0.03% | - | 16,520 | - | - | 28,744,000 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.02% | - | 10,805 | -600 | -5.26% | 18,801 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 121 | - | - | 211 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 46 | - | - | 80 | Mar 31, 2024 |
| FMR LLC | - | - | - | -23 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -449 | -100.00% | - | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -3,062,871 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,307 | -100.00% | - | Mar 31, 2024 |
| XTX TOPCO LTD | - | - | - | -15,506 | -100.00% | - | Mar 31, 2024 |
Connect Biopharma's largest institutional shareholder is BML CAPITAL MANAGEMENT, LLC, holding 3.74% of the company's total share outstanding, currently valued at $3.59M. The top 10 institutional shareholders own together 7.17% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 3.74% | 2.37% | 2,061,338 | -100 | -0.00% | 3,586,728 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.93% | 0.06% | 510,701 | -50,490 | -9.00% | 888,620 | Mar 31, 2024 |
| KEUDELL/MORRISON WEALTH MANAGEMENT | 0.04% | 0.01% | 19,700 | 8,500 | 75.89% | 34,278 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 0.00% | 239,900 | -58,100 | -19.50% | 417,000 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 35,000 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.02% | - | 10,805 | -600 | -5.26% | 18,801 | Mar 31, 2024 |
| BLACKROCK INC. | 1.89% | - | 1,040,067 | - | - | 1,809,717 | Mar 31, 2024 |
| RHUMBLINE ADVISERS | 0.03% | - | 16,520 | - | - | 28,744,000 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 27,961 | - | - | 48,652 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 46 | - | - | 80 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 121 | - | - | 211 | Mar 31, 2024 |
| FMR LLC | - | - | - | -23 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -449 | -100.00% | - | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -3,062,871 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,307 | -100.00% | - | Mar 31, 2024 |
| XTX TOPCO LTD | - | - | - | -15,506 | -100.00% | - | Mar 31, 2024 |
The largest Connect Biopharma shareholder by % of total assets is BML CAPITAL MANAGEMENT, LLC. The company owns 2.06M shares of Connect Biopharma (CNTB), representing 2.37% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 35,000 | Mar 31, 2024 |
| KEUDELL/MORRISON WEALTH MANAGEMENT | 0.04% | 0.01% | 19,700 | 8,500 | 75.89% | 34,278 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 121 | - | - | 211 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 46 | - | - | 80 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 27,961 | - | - | 48,652 | Mar 31, 2024 |
| RHUMBLINE ADVISERS | 0.03% | - | 16,520 | - | - | 28,744,000 | Mar 31, 2024 |
| BLACKROCK INC. | 1.89% | - | 1,040,067 | - | - | 1,809,717 | Mar 31, 2024 |
| FMR LLC | - | - | - | -23 | -100.00% | - | Mar 31, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 3.74% | 2.37% | 2,061,338 | -100 | -0.00% | 3,586,728 | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -449 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.02% | - | 10,805 | -600 | -5.26% | 18,801 | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,307 | -100.00% | - | Mar 31, 2024 |
| XTX TOPCO LTD | - | - | - | -15,506 | -100.00% | - | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.93% | 0.06% | 510,701 | -50,490 | -9.00% | 888,620 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 0.00% | 239,900 | -58,100 | -19.50% | 417,000 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -3,062,871 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Connect Biopharma's largest institutional buyer is COMMONWEALTH EQUITY SERVICES, LLC. The company purchased 20.00K stocks of CNTB, valued at $35.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -3,062,871 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 0.00% | 239,900 | -58,100 | -19.50% | 417,000 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.93% | 0.06% | 510,701 | -50,490 | -9.00% | 888,620 | Mar 31, 2024 |
| XTX TOPCO LTD | - | - | - | -15,506 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,307 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.02% | - | 10,805 | -600 | -5.26% | 18,801 | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -449 | -100.00% | - | Mar 31, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 3.74% | 2.37% | 2,061,338 | -100 | -0.00% | 3,586,728 | Mar 31, 2024 |
| FMR LLC | - | - | - | -23 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | 1.89% | - | 1,040,067 | - | - | 1,809,717 | Mar 31, 2024 |
| RHUMBLINE ADVISERS | 0.03% | - | 16,520 | - | - | 28,744,000 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 27,961 | - | - | 48,652 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 46 | - | - | 80 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 121 | - | - | 211 | Mar 31, 2024 |
| KEUDELL/MORRISON WEALTH MANAGEMENT | 0.04% | 0.01% | 19,700 | 8,500 | 75.89% | 34,278 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 35,000 | Mar 31, 2024 |
As of Mar 31 2024, Connect Biopharma's biggest institutional seller is RA CAPITAL MANAGEMENT, L.P.. The company sold -3.06M shares of CNTB, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 35,000 | Mar 31, 2024 |
Connect Biopharma's largest new institutional shareholder by number of shares is COMMONWEALTH EQUITY SERVICES, LLC, purchased 20.00K shares, valued at $35.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -3,062,871 | -100.00% | - | Mar 31, 2024 |
| XTX TOPCO LTD | - | - | - | -15,506 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,307 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -449 | -100.00% | - | Mar 31, 2024 |
| FMR LLC | - | - | - | -23 | -100.00% | - | Mar 31, 2024 |
Connect Biopharma's largest sold out institutional shareholder by shares sold is RA CAPITAL MANAGEMENT, L.P., sold -3.06M shares, valued at -, as of undefined.
Connect Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.38% | 1,040,067 | -85,195 | -7.57% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.09% | 781,599 | - | - | Jan 31, 2024 |
| Collaborative Investment Series Trust | 0.08% | 14,588 | - | - | Dec 31, 2023 |
| BlackRock Health Sciences Trust | 0.08% | 33,960 | - | - | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.02% | 219,833 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,616,871 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 624,300 | - | - | Feb 29, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 20,000 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 30,349 | - | - | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 38,093 | - | - | Dec 31, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 61,749 | - | - | Jan 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 44,354 | - | - | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 211 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 27,961 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 662,152 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 5,723 | - | - | Dec 29, 2023 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 259,682 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 276,192 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 3,561 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 8,985 | - | - | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 2,900 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 111 | - | - | Dec 31, 2023 |
Connect Biopharma's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 1.04M shares, compromising 0.38% of its total assets.
Connect Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 11 | -26.67% |
| 31 Dec, 23 | 15 | 15.38% |
| 30 Sep, 23 | 13 | -7.14% |
| 30 Jun, 23 | 14 | - |
| 31 Mar, 23 | 14 | -22.22% |
| 31 Dec, 22 | 18 | -18.18% |
| 30 Sep, 22 | 22 | -12.00% |
| 30 Jun, 22 | 25 | -7.41% |
| 31 Mar, 22 | 27 | - |
| 31 Dec, 21 | 27 | 35.00% |
| 30 Sep, 21 | 20 | 25.00% |
| 30 Jun, 21 | 16 | -38.46% |
| 31 Mar, 21 | 26 | - |
As of 31 Mar 24, 11 institutions are holding Connect Biopharma's shares, representing a decrease of -26.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 3,947,159 | -44.56% |
| 31 Dec, 23 | 7,119,105 | -29.36% |
| 30 Sep, 23 | 10,078,544 | -2.60% |
| 30 Jun, 23 | 10,347,988 | -5.06% |
| 31 Mar, 23 | 10,900,000 | -6.16% |
| 31 Dec, 22 | 11,616,039 | -8.84% |
| 30 Sep, 22 | 12,742,464 | -14.80% |
| 30 Jun, 22 | 14,956,738 | -15.53% |
| 31 Mar, 22 | 17,707,439 | 4.46% |
| 31 Dec, 21 | 16,950,595 | -12.61% |
| 30 Sep, 21 | 19,395,651 | 1.70% |
| 30 Jun, 21 | 19,072,268 | 23.92% |
| 31 Mar, 21 | 15,391,128 | - |
Connect Biopharma (CNTB) has 3.95M shares outstanding as of 31 Mar 24, down -44.56% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 7.17% | 4.27% |
| 31 Dec, 23 | 12.95% | 3.85% |
| 30 Sep, 23 | 18.33% | 5.17% |
| 30 Jun, 23 | 18.82% | 4.79% |
| 31 Mar, 23 | 19.83% | 4.44% |
| 31 Dec, 22 | 21.13% | 3.93% |
| 30 Sep, 22 | 23.18% | 2.83% |
| 30 Jun, 22 | 28.61% | 2.49% |
| 31 Mar, 22 | 33.87% | 3.22% |
| 31 Dec, 21 | 32.43% | 2.36% |
| 30 Sep, 21 | 37.10% | 2.79% |
| 30 Jun, 21 | 36.49% | 4.21% |
| 31 Mar, 21 | 29.44% | - |
As of 31 Mar 24, Connect Biopharma is held by 7.17% institutional shareholders, representing a 4.27% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 2 | -71.43% |
| 31 Dec, 23 | 7 | 133.33% |
| 30 Sep, 23 | 3 | -25.00% |
| 30 Jun, 23 | 4 | 33.33% |
| 31 Mar, 23 | 3 | -50.00% |
| 31 Dec, 22 | 6 | -25.00% |
| 30 Sep, 22 | 8 | -46.67% |
| 30 Jun, 22 | 15 | -25.00% |
| 31 Mar, 22 | 20 | - |
| 31 Dec, 21 | 20 | 100.00% |
| 30 Sep, 21 | 10 | 25.00% |
| 30 Jun, 21 | 8 | -69.23% |
| 31 Mar, 21 | 26 | - |
2 institutional shareholders have increased their position in CNTB stock as of 31 Mar 24 compared to 7 in the previous quarter (a -71.43% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 4 | -33.33% |
| 31 Dec, 23 | 6 | 200.00% |
| 30 Sep, 23 | 2 | -50.00% |
| 30 Jun, 23 | 4 | - |
| 31 Mar, 23 | 4 | -33.33% |
| 31 Dec, 22 | 6 | -40.00% |
| 30 Sep, 22 | 10 | 233.33% |
| 30 Jun, 22 | 3 | -40.00% |
| 31 Mar, 22 | 5 | - |
| 31 Dec, 21 | 5 | -16.67% |
| 30 Sep, 21 | 6 | 50.00% |
| 30 Jun, 21 | 4 | - |
| 31 Mar, 21 | - | - |
4 institutional shareholders have reduced their position in CNTB stock as of 31 Mar 24 compared to 6 in the previous quarter (a -33.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 11 | -26.67% | 3,947,159 | -44.56% | 7.17% | 4.27% | 2 | -71.43% | 4 | -33.33% |
| 31 Dec, 23 | 15 | 15.38% | 7,119,105 | -29.36% | 12.95% | 3.85% | 7 | 133.33% | 6 | 200.00% |
| 30 Sep, 23 | 13 | -7.14% | 10,078,544 | -2.60% | 18.33% | 5.17% | 3 | -25.00% | 2 | -50.00% |
| 30 Jun, 23 | 14 | - | 10,347,988 | -5.06% | 18.82% | 4.79% | 4 | 33.33% | 4 | - |
| 31 Mar, 23 | 14 | -22.22% | 10,900,000 | -6.16% | 19.83% | 4.44% | 3 | -50.00% | 4 | -33.33% |
| 31 Dec, 22 | 18 | -18.18% | 11,616,039 | -8.84% | 21.13% | 3.93% | 6 | -25.00% | 6 | -40.00% |
| 30 Sep, 22 | 22 | -12.00% | 12,742,464 | -14.80% | 23.18% | 2.83% | 8 | -46.67% | 10 | 233.33% |
| 30 Jun, 22 | 25 | -7.41% | 14,956,738 | -15.53% | 28.61% | 2.49% | 15 | -25.00% | 3 | -40.00% |
| 31 Mar, 22 | 27 | - | 17,707,439 | 4.46% | 33.87% | 3.22% | 20 | - | 5 | - |
| 31 Dec, 21 | 27 | 35.00% | 16,950,595 | -12.61% | 32.43% | 2.36% | 20 | 100.00% | 5 | -16.67% |
| 30 Sep, 21 | 20 | 25.00% | 19,395,651 | 1.70% | 37.10% | 2.79% | 10 | 25.00% | 6 | 50.00% |
| 30 Jun, 21 | 16 | -38.46% | 19,072,268 | 23.92% | 36.49% | 4.21% | 8 | -69.23% | 4 | - |
| 31 Mar, 21 | 26 | - | 15,391,128 | - | 29.44% | - | 26 | - | - | - |
CNTB Ownership FAQ
Who Owns Connect Biopharma?
Connect Biopharma is owned by institutional shareholders (7.17%), insiders (41.27%), and public (51.56%). The largest institutional shareholder of Connect Biopharma is BML CAPITAL MANAGEMENT, LLC (3.74% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.38% of total shares).
Who are the major institutional shareholders of Connect Biopharma?
Connect Biopharma's major institutional shareholders are BML CAPITAL MANAGEMENT, LLC, BLACKROCK INC., UBS OCONNOR LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 7.05% of the company's share outstanding.
How many Connect Biopharma shareholders are there?
As of Mar 2024, there are 11 institutional shareholders of Connect Biopharma.
What percentage of Connect Biopharma is owned by BML CAPITAL MANAGEMENT, LLC?
BML CAPITAL MANAGEMENT, LLC owns 2.06M shares of Connect Biopharma, representing 3.74% of the company's total shares outstanding, valued at $3.59M (as of Mar 2024).
What percentage of Connect Biopharma is owned by BLACKROCK INC?
As of Mar 2024, BLACKROCK INC holds 1.04M shares of Connect Biopharma (CNTB), compromising 1.89% of the company, valued at $1.81M.
What percentage of Connect Biopharma is owned by UBS OCONNOR LLC?
UBS OCONNOR LLC is the third largest holder of Connect Biopharma. The company owns 510.7K of the company's shares outstanding (worth $888.62K).